AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 274: E162-E171, 1998;
0193-1849/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chu, C. A.
Right arrow Articles by Cherrington, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chu, C. A.
Right arrow Articles by Cherrington, A. D.
Vol. 274, Issue 1, E162-E171, January 1998

Effect of a selective rise in sinusoidal norepinephrine on HGP is due to an increase in glycogenolysis

Chang An Chu, Dana K. Sindelar, Doss W. Neal, Eric J. Allen, E. Patrick Donahue, and Alan D. Cherrington

Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0615

To determine the effect of a selective rise in liver sinusoidal norepinephrine (NE) on hepatic glucose production (HGP), norepinephrine (50 ng · kg-1 · min-1) was infused intraportally (Po-NE) for 3 h into five 18-h-fasted conscious dogs with a pancreatic clamp. In the control protocol, NE (0.2 ng · kg-1 · min-1) and glucose were infused peripherally to match the arterial NE and blood glucose levels in the Po-NE group. Hepatic sinusoidal NE levels rose ~30-fold in the Po-NE group but did not change in the control group. The arterial NE levels did not change significantly in either group. During the portal NE infusion, HGP increased from 1.9 ± 0.2 to 3.5 ± 0.4 mg · kg-1 · min-1 (15 min; P < 0.05) and then gradually fell to 2.4 ± 0.4 mg · kg-1 · min-1 by 3 h. HGP in the control group did not change (2.0 ± 0.2 to 2.0 ± 0.2 mg · kg-1 · min-1) for 15 min but then gradually fell to 1.1 ± 0.2 mg · kg-1 · min-1 by the end of the study. Because the fall in HGP from 15 min on was parallel in the two groups, the effect of NE on HGP (the difference between HGP in the two groups) did not decline over time. Gluconeogenesis did not change significantly in either group. In conclusion, elevation in hepatic sinusoidal NE significantly increases HGP by selectively stimulating glycogenolysis. Compared with the previously determined effects of epinephrine or glucagon on HGP, the effect of NE is, on a molar basis, less potent but nore sustained over time.

gluconeogenesis; adrenergic receptors


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Cardin, M. J. Pagliassotti, M. C. Moore, D. S. Edgerton, M. Lautz, B. Farmer, D. W. Neal, and A. D. Cherrington
Vagal cooling and concomitant portal norepinephrine infusion do not reduce net hepatic glucose uptake in conscious dogs
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2004; 287(4): R742 - R748.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. A. Chu, P. Galassetti, K. Igawa, D. K. Sindelar, D. W. Neal, M. Burish, and A. D. Cherrington
Interaction of free fatty acids and epinephrine in regulating hepatic glucose production in conscious dogs
Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E291 - E301.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. H. Coker, Y. Koyama, J. C. Denny, R. C. Camacho, D. B. Lacy, and D. H. Wasserman
Prevention of Overt Hypoglycemia During Exercise: Stimulation of Endogenous Glucose Production Independent of Hepatic Catecholamine Action and Changes in Pancreatic Hormone Concentration
Diabetes, May 1, 2002; 51(5): 1310 - 1318.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. H. Coker, L. Simonsen, J. Bulow, D. H. Wasserman, and M. Kjar
Stimulation of splanchnic glucose production during exercise in humans contains a glucagon-independent component
Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E918 - E927.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
R. J. Geor, K. W. Hinchcliff, and R. A. Sams
beta -Adrenergic blockade augments glucose utilization in horses during graded exercise
J Appl Physiol, September 1, 2000; 89(3): 1086 - 1098.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. A. Chu, D. K. Sindelar, K. Igawa, S. Sherck, D. W. Neal, M. Emshwiller, and A. D. Cherrington
The direct effects of catecholamines on hepatic glucose production occur via alpha 1- and beta 2-receptors in the dog
Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E463 - E473.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. Shiota, P. Jackson, P. Galassetti, M. Scott, D. W. Neal, and A. D. Cherrington
Combined intraportal infusion of acetylcholine and adrenergic blockers augments net hepatic glucose uptake
Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E544 - E552.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
E. Cersosimo, I. N. Zaitseva, and M. Ajmal
Effects of beta -adrenergic blockade on hepatic and renal glucose production during hypoglycemia in conscious dogs
Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E792 - E797.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. A. Chu, S. M. Sherck, K. Igawa, D. K. Sindelar, D. W. Neal, M. Emshwiller, and A. D. Cherrington
Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs
Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E402 - E411.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online